CLINICAL_TRIALS trial_result · 2026-03-30

Clinical Trial Update: KET-RO Plus RO DBT for Treatment Resistant Depression [Phase 1]

Summary

Phase 1 trial evaluating the combination of ketamine with RO-DBT for treatment-resistant depression has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

Snippet

Sponsor: Washington University School of Medicine | Conditions: Treatment Resistant Depression | Phase 1 | Status: COMPLETED | Results posted: 2026-03-30